CN Stock MarketDetailed Quotes
600420 Shanghai Shyndec Pharmaceutical
- 12.26
- -0.43-3.39%
Market Closed Dec 13 15:00 CST
16.44BMarket Cap15.19P/E (TTM)
12.68High12.26Low183.57KlotVolume12.68Open12.69Pre Close227.45MTurnover1.37%Turnover Ratio23.76P/E (Static)1.34BShares14.4152wk High1.26P/B16.44BFloat Cap7.4152wk Low13.96Limit Up1.34BShs Float29.32Historical High11.42Limit Down3.31%Amplitude0.07Historical Low0.20Dividend TTM12.39Avg Price120.23KlotAsk1.63%Div YieldTTM100Lot Size62.21KlotBid
Shanghai Shyndec Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 0.49%8.06B | 4.14%5.54B | 19.10%2.93B | -8.67%11.31B | -9.96%8.02B | -6.33%5.32B | -10.41%2.46B | -6.52%12.39B | -9.85%8.91B | -8.97%5.68B |
| Refunds of taxes and levies | -47.21%31.04M | -59.65%19.95M | -73.58%10.88M | -71.71%75.85M | -69.38%58.81M | -57.43%49.45M | 119.02%41.19M | 23.27%268.08M | 20.02%192.03M | 28.05%116.18M |
| Cash received relating to other operating activities | -14.45%414.63M | 111.26%890.16M | 20.17%201.07M | -27.74%605.95M | -37.25%484.68M | -35.02%421.36M | 104.67%167.32M | 31.69%838.57M | 60.01%772.35M | 188.70%648.47M |
| Cash inflows from operating activities | -0.68%8.51B | 11.39%6.45B | 17.74%3.14B | -11.11%11.99B | -13.25%8.57B | -10.14%5.79B | -6.25%2.67B | -4.34%13.49B | -6.20%9.88B | -1.69%6.45B |
| Goods services cash paid | 5.26%3.39B | 9.71%2.32B | 23.59%1.17B | -10.05%4.37B | -10.57%3.22B | -8.44%2.11B | -3.93%948.99M | -15.34%4.86B | -20.12%3.6B | -20.51%2.31B |
| Staff behalf paid | 5.86%1.3B | 4.78%887.42M | 6.04%510.64M | 7.69%1.63B | 8.82%1.23B | 8.08%846.94M | 3.06%481.54M | 1.47%1.52B | -0.76%1.13B | 0.12%783.65M |
| All taxes paid | -9.17%591.15M | -7.13%455.51M | -3.79%239.88M | -6.58%827.48M | -5.27%650.82M | -0.70%490.5M | 2.44%249.33M | -3.07%885.73M | -8.36%687.02M | -15.62%493.96M |
| Cash paid relating to other operating activities | -40.61%1.2B | -31.91%973.32M | -29.60%505.11M | 1.99%3.44B | -18.95%2.02B | -10.22%1.43B | -1.62%717.45M | -21.09%3.37B | -9.65%2.49B | -13.48%1.59B |
| Cash outflows from operating activities | -8.96%6.48B | -5.03%4.63B | 1.30%2.43B | -3.42%10.27B | -9.98%7.12B | -5.75%4.88B | -1.25%2.4B | -14.39%10.64B | -13.60%7.91B | -15.29%5.18B |
| Net cash flows from operating activities | 40.09%2.03B | 99.30%1.82B | 163.91%711.4M | -39.76%1.72B | -26.41%1.45B | -28.07%911.7M | -35.33%269.56M | 70.01%2.86B | 43.19%1.97B | 185.63%1.27B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 68.63%2.29M | ---- | ---- | --2.01M | --1.36M | --1.36M | --1.36M | ---- | ---- | ---- |
| Cash received from returns on investments | -73.58%6.88M | ---- | ---- | --26.19M | --26.05M | ---- | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,008.27%14.73M | 45.01%1.2M | 253.61%811.98K | 119.04%10.96M | -71.35%1.33M | -64.42%825.42K | -83.19%229.62K | 34.44%5M | 116.08%4.64M | 19.33%2.32M |
| Cash received relating to other investing activities | --677.57M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 2,341.07%701.47M | -45.13%1.2M | -48.79%811.98K | 682.65%39.16M | 519.56%28.74M | -5.97%2.18M | 16.06%1.59M | -62.00%5M | -59.99%4.64M | -14.78%2.32M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -37.26%156.03M | -36.64%110.22M | -57.34%56.07M | 16.18%357.19M | 3.03%248.69M | 3.81%173.96M | -0.74%131.45M | -41.04%307.44M | -41.79%241.38M | -44.20%167.57M |
| Cash paid relating to other investing activities | 285.01%1.9B | --497M | --130M | --1.04B | --493.5M | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 177.02%2.06B | 249.06%607.22M | 41.55%186.07M | 356.04%1.4B | 207.48%742.19M | 3.81%173.96M | -0.74%131.45M | -41.04%307.44M | -41.79%241.38M | -44.20%167.57M |
| Net cash flows from investing activities | -89.86%-1.35B | -252.80%-606.02M | -42.66%-185.26M | -350.64%-1.36B | -201.37%-713.46M | -3.95%-171.78M | 0.91%-129.86M | 40.50%-302.44M | 41.27%-236.74M | 44.47%-165.25M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.19B | ---- | ---- |
| Cash from borrowing | 11.11%50M | -20.00%20M | ---- | -98.08%45M | -98.08%45M | -98.85%25M | ---- | -36.35%2.35B | -33.65%2.35B | -22.75%2.17B |
| Cash inflows from financing activities | 11.11%50M | -20.00%20M | ---- | -98.73%45M | -98.08%45M | -98.85%25M | ---- | -4.11%3.53B | -33.65%2.35B | -22.75%2.17B |
| Borrowing repayment | -94.02%45M | -96.56%25M | ---- | -76.37%752.8M | -73.56%752.8M | -69.31%727.8M | -49.33%727.8M | -4.75%3.19B | -1.29%2.85B | 11.66%2.37B |
| Dividend interest payment | 12.07%379.37M | 18.34%172.8M | -43.93%36.1M | 4.79%364.16M | 0.36%338.5M | 11.57%146.01M | 24.84%64.39M | -4.79%347.52M | 23.14%337.3M | -43.30%130.87M |
| -Including:Cash payments for dividends or profit to minority shareholders | -6.89%81.04M | -91.98%6.95M | -11.90%4.5M | 7.37%174.8M | 1.45%87.03M | 28.14%86.66M | 80.60%5.11M | 6.72%162.81M | 20.96%85.79M | -1.29%67.63M |
| Cash payments relating to other financing activities | 125.16%32.7M | -13.46%11.92M | 68.97%8.91M | -95.08%21.43M | -96.66%14.52M | -96.81%13.77M | -98.77%5.27M | -31.72%435.36M | -37.55%434.2M | 161.24%431.4M |
| Cash outflows from financing activities | -58.67%457.06M | -76.37%209.72M | -94.36%45.01M | -71.32%1.14B | -69.44%1.11B | -69.75%887.59M | -58.42%797.47M | -8.71%3.97B | -6.10%3.62B | 16.43%2.93B |
| Net cash flows from financing activities | 61.63%-407.06M | 78.01%-189.72M | 94.36%-45.01M | -151.17%-1.09B | 16.63%-1.06B | -13.02%-862.59M | -267.20%-797.47M | 34.28%-435.32M | -300.18%-1.27B | -362.93%-763.21M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -0.95%24.55M | 1,244.01%18.51M | 140.42%2.5M | -65.97%32.07M | -62.19%24.79M | -91.65%1.38M | 14.65%-6.18M | 335.14%94.24M | 342.58%65.56M | 170.01%16.5M |
| Net increase in cash and cash equivalents | 195.52%289.39M | 957.31%1.04B | 172.84%483.63M | -131.82%-703.83M | -158.02%-302.95M | -134.11%-121.28M | -1,182.14%-663.95M | 371.77%2.21B | -16.43%522.15M | -13.89%355.52M |
| Add:Begin period cash and cash equivalents | -12.06%5.13B | -12.06%5.13B | -12.01%5.13B | 61.06%5.83B | 61.06%5.83B | 61.06%5.83B | 61.06%5.83B | 14.87%3.62B | 14.87%3.62B | 14.87%3.62B |
| End period cash equivalent | -2.02%5.42B | 8.00%6.17B | 8.65%5.62B | -12.06%5.13B | 33.46%5.53B | 43.62%5.71B | 40.36%5.17B | 61.06%5.83B | 9.69%4.14B | 11.54%3.98B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
